Leading Manufacturer and Exporter of Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg in India

Taj Pharmaceuticals Ltd, headquartered in Vapi, Gujarat, India, is a renowned manufacturer, exporter, and supplier of Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg. Recognized for its commitment to quality, efficacy, and international standards, Taj Pharma has become a trusted name in the global pharmaceutical market, catering to clients in India, Africa, the Middle East, and Latin America (LATAM).

Rilmenidine Dihydrogen Phosphate Tablets (1mg) are widely used in the management of hypertension (high blood pressure) and cardiovascular risk reduction, offering patients long-term safety and therapeutic benefits.

About Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg

Rilmenidine Dihydrogen Phosphate is a centrally acting antihypertensive medication, classified as an imidazoline receptor agonist. It works by reducing sympathetic nervous system activity, leading to lower blood pressure levels without causing excessive drowsiness or significant side effects.

Key features of Rilmenidine Dihydrogen Phosphate Tablets 1mg:

• Effective in monotherapy and combination therapy for hypertension
• Minimizes cardiovascular risks including stroke and heart attack
• Long-term safety profile, suitable for chronic use
• Well-tolerated in elderly patients and those with mild kidney impairment

Therapeutic Indications

Taj Pharmaceuticals manufactures Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg for the following therapeutic uses:

• Management of primary hypertension (high blood pressure)
• Prevention of heart attacks and strokes in hypertensive patients
• Post-myocardial infarction care, to improve survival rates
• Reduction of cardiovascular morbidity in patients with chronic hypertension

By reducing the strain on the heart and blood vessels, this medication plays a critical role in long-term cardiovascular health.

Why Choose Taj Pharmaceuticals Ltd for Rilmenidine Dihydrogen Phosphate Tablets?

1. World-Class Manufacturing Facilities

Taj Pharma operates state-of-the-art manufacturing plants in Vapi, Gujarat, equipped with GMP, WHO-GMP, and ISO-certified facilities. Our quality control laboratories ensure that each batch meets international pharmacopeial standards, offering unmatched purity and efficacy.

2. Global Export Network

Our Rilmenidine Dihydrogen Phosphate Tablets (1mg) are exported across India and internationally to:

• Africa – Nigeria, Kenya, Ghana, and South Africa
• Middle East – UAE, Saudi Arabia, Iraq, and Jordan
• LATAM – Peru, Chile, and Mexico

This global footprint makes Taj Pharma a preferred partner for international distributors and PCD pharma franchise associates.

3. Commitment to Quality and Compliance

We follow rigorous quality assurance processes, ensuring compliance with:

• WHO-GMP guidelines
• US FDA, UK MHRA, and EU GMP standards (for specific markets)
• Stringent stability and bioavailability testing

Our high-quality Rilmenidine tablets maintain consistent therapeutic outcomes for patients worldwide.

Dosage and Administration

• Recommended Dose: 1 mg once daily, preferably on an empty stomach
• Administration Route: Oral
• Long-term Therapy: Works best when taken consistently over time
• Precaution: Always follow the physician’s advice regarding duration and dosage

Caution & Warnings

While Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg are generally safe, the following precautions should be observed:

• Avoid sudden discontinuation, as it may lead to a rebound increase in blood pressure
• Use with caution in patients with severe renal impairment
• Pregnant or breastfeeding women should consult a physician before use
• Report any unusual dizziness, fatigue, or hypotension to the healthcare provider

Storage Guidelines

To maintain potency and safety, store the tablets as follows:

• Temperature: Below 30°C, in a cool and dry place
• Packaging: Blister packs to prevent moisture exposure
• Keep out of reach of children

Technical Specification

• Product Name: Rilmenidine Dihydrogen Phosphate Tablets
• Brand Name: Cadrest
• Strength: 1mg
• Dosage Form: Oral tablet
• Route of Administration: Oral
• Packing: Blister packs / 10 tablets per strip / 100 tablets per box
• Pack Insert/Leaflet: Included
• Regulatory Documents: WHO-GMP, COA, COPP, FSC (as per market requirement)
• Therapeutic Use: Antihypertensive medication
• Indication: Treatment of hypertension and cardiovascular risk reduction
• Storage: Store below 30°C, dry place, away from direct sunlight
• Dosage: As prescribed by the physician

Rilmenidine Dihydrogen Phosphate Tablets – PCD Pharma Franchise Opportunity

Taj Pharmaceuticals Ltd offers PCD Pharma Franchise partnerships for Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg. Partners benefit from:

• Exclusive marketing rights in their territory
• High-quality promotional materials and product support
• Competitive pricing for domestic and export markets
• Timely delivery with robust supply chain management

This makes Taj Pharma the ideal partner for distributors, hospital buyers, and pharmaceutical importers.

Why Taj Pharma is a Trusted Global Supplier

Our dedication to excellence and patient-centric manufacturing has positioned us as:

• Top Rilmenidine Dihydrogen Phosphate Tablets Manufacturer in India
• Leading Exporter to Africa, the Middle East, and LATAM
• Reliable Partner for PAN India Distribution and PCD Franchise

We combine affordability with uncompromised quality, supporting better patient outcomes worldwide.

Contact Taj Pharmaceuticals Ltd

If you are a pharmaceutical distributor, importer, or hospital buyer, connect with Taj Pharma to source premium Rilmenidine Dihydrogen Phosphate Tablets at the best industry prices.

📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
Tel. No.: +91-22-2637 4592 / 4593
📠 Fax: +91-22-2634 1274